News

More than 1 in 4 Canadians’ lives are impacted by vision loss and blindness, yet a recent Ipsos public opinion survey conducted on behalf of Fighting Blindness Canada (FBC) shows more Canadians…
Read More about COVID-19 impacts Canadians Getting Diagnosed for Blinding Eye Diseases
Meet longtime Fighting Blindness Canada (FBC) supporters Mort and Marilyn Ritz: Mort and Marilyn were both born and raised in Montreal, Quebec. They met on a blind date and have now been…
Read More about Mort and Marilyn Ritz support vision research into the future
At Fighting Blindness Canada, we often connect with pharmaceutical companies who are developing treatments for blinding eye diseases and are working to understand the patient voice. We have developed a brief survey…
Read More about AN INTRODUCTION TO PATIENT ADVISORY GROUPS
The award will support promising early career clinician-scientists undertaking cutting-edge vision research. Fighting Blindness Canada (FBC) is pleased to announce the three recipients of the 2021 Clinician Scientist Emerging Leader Award (CSEL)….
Read More about Fighting Blindness Canada announces winners of the 2021 Clinician Scientist Emerging Leader Award
In this third wave of COVID-19, the undersigned Canadian health charities urge provincial governments to shorten the interval between COVID-19 vaccine doses for residents who are living with pre-existing health conditions. Our…
Read More about Vulnerable Populations in Canada Need Earlier Access to Second Doses of COVID-19 Vaccines
A new strategic research and development (R&D) alliance was announced on May 17, 2021 between BlueRock Therapeutics LP, FUJIFILM Cellular Dynamics Inc (FCDI) and Opsis Therapeutics LLC to develop new cell therapies…
Read More about $70M US alliance to develop new cell therapies for blinding eye diseases building on FBC funded researchJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.